Do Human iPSC-Derived Cardiomyocytes Cultured on PLA Scaffolds Induce Expression of CD28/CTLA-4 by T Lymphocytes?
Many research groups have developed various types of tissue-engineered cardiac constructs. However, the immunological properties of such artificial tissues are not yet fully understood. Previously, we developed microfiber scaffolds carrying human iPSC-derived cardiomyocytes (hiPSC-CM). In this work,...
Main Authors: | David Sergeevichev, Victor Balashov, Victoria Kozyreva, Sophia Pavlova, Maria Vasiliyeva, Alexander Romanov, Elena Chepeleva |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Journal of Functional Biomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4983/13/1/6 |
Similar Items
-
iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
by: Eline Simons, et al.
Published: (2023-01-01) -
Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
by: Sofija Vučković, et al.
Published: (2022-07-01) -
Sarcomere Disassembly and Transfection Efficiency in Proliferating Human iPSC-Derived Cardiomyocytes
by: Qianliang Yuan, et al.
Published: (2022-01-01) -
iPSC-Derived Cardiomyocytes as a Disease Model to Understand the Biology of Congenital Heart Defects
by: Chithra K. Pushpan, et al.
Published: (2024-08-01) -
Impact of Neurons on Patient-Derived Cardiomyocytes Using Organ-On-A-Chip and iPSC Biotechnologies
by: Albin A. Bernardin, et al.
Published: (2022-11-01)